Pyrimidine Substrates for AGT Label Transfer

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting and manipulating proteins of interest using O6-alkylguanine-DNA alkyltransferases (AGT) and AGT fusion proteins are limited by the lack of effective substrates that can transfer labels efficiently, which hampers the detection and manipulation of these proteins in biological systems.

Innovation Solution

The development of pyrimidines of formula (I) as substrates, where R1 is hydrogen, lower alkyl, halogen, cyano, trifluoromethyl, or azido, and R2 is a linker connecting a label or multiple labels, enabling the transfer of labels from these pyrimidines to O6-alkylguanine-DNA alkyltransferases (AGT) and AGT fusion proteins, facilitating detection and manipulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If pyrimidines of formula (I) are used as substrates for O6-alkylguanine-DNA alkyltransferase, then label transfer efficiency to AGT fusion proteins is improved, but substrate structure complexity increases

Engineering Contradiction:
Improvelabel transfer efficiencyVSAvoidsubstrate structure complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The pyrimidine substrate is divided into distinct functional segments: the pyrimidine ring (R1) that interacts with AGT, the linker (R2) that provides flexibility and spacing, and the label (L) that enables detection. This segmentation allows each component to be optimized independently for its specific function while maintaining overall efficiency.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The linker group R2 acts as an intermediary between the pyrimidine ring and the label. It mediates the connection by providing appropriate spacing and flexibility, allowing the pyrimidine to bind to AGT while positioning the label for efficient transfer without steric hindrance.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If diverse substituents (R1) are introduced on pyrimidine to enhance labeling efficiency, then detection sensitivity is improved, but synthesis difficulty increases

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsynthesis difficulty
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

Different substituents (R1) are introduced at specific positions on the pyrimidine ring to optimize local interactions with AGT. For example, electron-withdrawing groups at certain positions enhance binding affinity and label transfer efficiency, while the core pyrimidine structure remains relatively simple for synthesis.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

Systematic variation of substituent parameters (type, position, electron-withdrawing/donating properties) on the pyrimidine ring allows optimization of detection sensitivity. By changing these chemical parameters, different levels of labeling efficiency can be achieved while maintaining reasonable synthetic accessibility.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If multiple labels are attached to pyrimidine substrates, then protein manipulation capability is enhanced, but substrate complexity and cost increase

Engineering Contradiction:
Improveprotein manipulation capabilityVSAvoidsubstrate complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The pyrimidine substrate design with multiple label positions enables a single substrate type to serve multiple detection and manipulation functions. Different label combinations can be used for different applications (e.g., FRET pairs for distance measurement, fluorescent labels for imaging, biotin for affinity purification), making the substrate system universally applicable.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

Multiple label types are combined on a single pyrimidine substrate molecule. This merging of multiple detection/manipulation capabilities into one substrate eliminates the need for separate substrates for different functions, enhancing versatility while managing complexity through integrated design.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These pyrimidines allow for efficient labeling and detection of AGT fusion proteins, enhancing the ability to study and manipulate these proteins in biological systems, including in vivo cell culture applications, by transferring labels to the AGT proteins, thereby improving the sensitivity and specificity of protein detection and analysis.

Implementation Method 1

O6-alkylguanine-DNA alkyltransferases (AGT) and AGT fusion proteins, facilitating detection and manipulation

Methodology Applied
Scientific EffectEnzymatic reaction: Enzyme

Data Source

PatentEP1874738B1Pyrimidines reacting with o6-alkylguanine-DNA alkyltransferase
Publication Date: 2016.06.29 COVALYS BIOSCI
  • EP1874738B1 patent drawingFigure 1A~1C
  • EP1874738B1 patent drawingFigure 2A~2C
  • EP1874738B1 patent drawingFigure 3A~3C

AI summary

The invention relates to pyrimidines suitable as substrates for O6-alkylguanine-DNA alkyltransferases (AGT) of formula (I) wherein R1 is hydrogen, lower alkyl, halogen, cyano, trifluoromethyl or azido; R2 is a linker; and L is a label or a plurality of same or different labels. The invention further relates to methods of transferring a label from pyrimidines of formula (I) to O6-alkylguanine-DNA alkyltransferases (AGT) and AGT fusion proteins.